Literature DB >> 8284640

Seroprevalence of Chlamydia pneumoniae in Taiwan.

J H Wang1, Y C Liu, D L Cheng, M Y Yeng, Y S Chen, B C Chen.   

Abstract

Chlamydia pneumoniae (TWAR) is a relatively newly discovered respiratory tract pathogen which was first isolated in Taiwan. In order to describe the seroepidemiology of C. pneumoniae in Taiwan, we evaluated 1,085 stored serum samples: 904 from patients, 97 from umbilical cord blood samples, and 84 from medical personnel at the Veterans General Hospital-Kaohsiung, between January 1 and April 30, 1991. Antibodies were determined by the use of a microimmunofluorescence test using elementary bodies of C. pneumoniae AR-39 as antigen. Sera were tested with screening titres of 16 and 512 for immunoglobulin G antibody. The antibody prevalence was found to be 23.1% in young children (6 months to 10 years old), rising to 66.7% in teenagers, and to 96.2% in older age groups. These rates were higher than any reported earlier. The progressively increasing rates of seropositivity found in older individuals indicated a surge of reinfection in these age groups. Only 5 cases were found with micro-IF IgG titres equal to or greater than 512. All were asymptomatic according to the hospital records. In addition to a high prevalence rate in Taiwan, the data also showed high infection rates in teenagers and elderly people.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8284640     DOI: 10.3109/00365549309008544

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  7 in total

1.  Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community acquired pneumonia.

Authors:  R Chaudhry; N Nazima; B Dhawan; S K Kabra
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

2.  A population based seroepidemiological survey of Chlamydia pneumoniae infections in schoolchildren.

Authors:  G Dal Molin; B Longo; T Not; A Poli; C Campello
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

3.  Detection of Helicobacter pylori and Chlamydia pneumoniae genes in primary orbital lymphoma.

Authors:  Chi-Chao Chan; Defen Shen; Manabu Mochizuki; John A Gonzales; Hunter K L Yuen; Yan Guex-Crosier; Phuc Lehoang
Journal:  Trans Am Ophthalmol Soc       Date:  2006

4.  Prevalence of Chlamydia pneumoniae specific antibodies in different clinical situations and healthy subjects in Izmir, Turkey.

Authors:  M Gencay; D Dereli; E Ertem; D Serter; M Puolakkainen; P Saikku; B Boydak; S Dereli; B Ozbakkaloglu; A Yorgancioglu; E Tez
Journal:  Eur J Epidemiol       Date:  1998-07       Impact factor: 8.082

5.  Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections.

Authors:  R P Verkooyen; D Willemse; S C Hiep-van Casteren; S A Joulandan; R J Snijder; J M van den Bosch; H P van Helden; M F Peeters; H A Verbrugh
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

6.  A retrospective seroepidemiologic survey of Chlamydia pneumoniae infection in patients in Beijing between 2008 and 2017.

Authors:  Jingtao Cui; Wenjuan Yan; Hongjie Xie; Shaoxia Xu; Qiaofeng Wang; Weihong Zhang; Anping Ni
Journal:  PLoS One       Date:  2018-11-07       Impact factor: 3.240

7.  Multi-peptide ELISAs overcome cross-reactivity and inadequate sensitivity of conventional Chlamydia pneumoniae serology.

Authors:  Kh Shamsur Rahman; Bernhard Kaltenboeck
Journal:  Sci Rep       Date:  2019-10-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.